Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Cell2Cure Logo
Cell2Cure CB Rank
735350
Heat Score
57
Cell2Cure is a biotherapeutic company that develops allogeneic adipose tissue-derived mesenchymal stromal cells.
Founded
obfuscation
Private Copenhagen, Hovedstaden, Denmark1-10 cell2cure.com
Biopharma
Biotechnology
Test and Measurement
Overview

Cell2Cure
Heat Score
57

Growth Score
pts
in past quarter
Heat Score 57
-14 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Cell2Cure

CB Rank
735350
Cell2Cure is a biotherapeutic company that develops allogeneic adipose tissue-derived mesenchymal stromal cells.
Founded
obfuscation
Private Copenhagen, Hovedstaden, Denmark1-10 cell2cure.com
Biopharma
Biotechnology
Test and Measurement

Details

Legal Name Cell2Cure, ApS.
Operating Status Active
Company Type For Profit
Phone Number +45 2178 2824
Contact Email contact@cell2cure.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

C2C-ASC (Allogeneic Adipose Tissue-Derived Mesenchymal Stromal Cells)
An off-the-shelf allogeneic mesenchymal stromal cell product derived from adipose tissue, intended for therapeutic use in various inflammatory, ischemic, and fibrotic diseases.
Sublicense Agreement with Endeavour Cells ApS
A sublicensing arrangement allowing Endeavour Cells ApS to develop, manufacture, and commercialize C2C-ASC for neurodevelopmental disorders including autism spectrum disorder and related conditions.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Contacts 1
News

News and Press

News•Jul 19, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$27.3KThis year, Cell2Cure is projected to spend $27.3K on IT, according to Aberdeen.

Active Website Tech Count

2Cell2Cure is actively using 2 technologies for its website, according to BuiltWith. These include Common Crawl and  CommonCrawl Top 50m.

Total IP

1Cell2Cure has 1 registered trademark in the 'Chemical substances' class, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Cell2Cure's headquarters? Cell2Cure is located in Copenhagen, Hovedstaden, Denmark.Who are Cell2Cure's competitors? Alternatives and possible competitors to Cell2Cure may include Longeveron, Mesoblast, and  BioSenic.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(9fd75b2 1)
|